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Abstract
Objective:  Among   the   inherited   cardiomyopathies,   Arrhythmogenic   right   ventricular 
dysplasia/cardiomyopathy is unique with a peculiar pathology of fibro-fatty replacement. Studies 
have been carried out all over the world and several groups have reported clinical heterogeneity 
in manifestation of ARVD/C related symptoms. Present study is an attempt to identify the 
clinical profile of ARVD/C patients from Asian Indian origin.                                                   
Methods: 31 patients in the span of three years were diagnosed with ARVD/C. Diagnosis was 
based on proposed task force criteria.                                                                                               
Results: The mean age at diagnosis was 32.9 ± 16.4 years with slight tilt in male to female ratio 
(1.46). About 80% cases had palpitations, syncope in 45.16% and dyspnea in 22.5%, whereas 
16% of patients were asymptomatic. About 50% of patients revealed a family history of 
confirmed ARVD/C or sudden death of a family member without any known cause. ECG 
showed T-wave inversion in about 60% cases, prolongation of QRS was observed in 20% cases. 
RV dilatation was observed in 80% of patients and 66.7% showed systolic dysfunction. RV free 
wall motion abnormalities were found in 33% patients. Most of the early onset cases with less 
than 30 years of age showed family history indicative of ARVD/C. Familial study in three 
patients indicated early onset of condition in younger generations in two families.              
Conclusion: ARVD/C in India shows relatively early age at onset when compared with other 
Asian populations with more than half of patients showing the disease below the age of 30 years. 
History in most of the early onset cases revealed family history indicating strong genetic 
influence.
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Introduction
            While Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is one of 
the rare forms of cardiomyopathies, it is the second most common cause of sudden death of 
young adults world-wide1. Presenting symptoms include ventricular arrhythmias, manifested as 
palpitations, sustained ventricular tachycardia, pre-syncope (light-headedness), blackout or 
syncope, heart failure and even sudden death in some cases. But the non-specific signs may 
include abdominal pain, decreased exercise tolerance, dizziness, dyspnea (with exertion), 
fatigue, mental confusion and peripheral edema. The pathological hallmark of this condition is 
the replacement of right ventricular myocardium with fibro-fatty tissue.                                    
            The condition has been reported to have genetic etiology, with about seven genes already 
identified to carry mutations. Along with the genetic heterogeneity, ARVD/C shows clinical 
heterogeneity, where a patient may present symptoms of ventricular premature complexes, 
cardiomegaly or ventricular tachycardia of right ventricular origin in childhood or as an adult2. 
Studies carried out so far by various groups across the world have shown significant variability 
in expression of ARVD/C phenotype in different populations3-5. The present report is an attempt 
to describe the clinical spectrum of this condition in Indian population.                       
Methods
            Since the incidence of ARVC is unknown in Indian population, no sample size was 
predetermined at the beginning of the study. All the cases obtained in the span of three years 
(from 2004 to 2007), viz., 31 ARVD/C cases  reported at Care Hospitals and National Institute 
of Medical Sciences (NIMS) Hyderabad, India were included in the study. Among these, 4 have 
ICD implanted.  Parameters such as age, age at onset, presenting symptoms, electrocardiogaphic 
and echocardiographic features and the compliance of these patients with proposed task force 
criteria6 for confirmed diagnosis of ARVD/C  were analysed. According to the standardized 
criteria a patient is confirmed with ARVC, if he/she satisfies two major criteria; one major and 
two   minor   criteria   or   four   minor   criteria.                                                            
            Informed consent of all the patients participating in the study was obtained along with 
Institutional Ethics Committee (IEC) approval. An IEC approved data collection form was used 
to obtain all the parameters required for diagnosis6. ECG and Echocardiography and other 
diagnostic tests were performed following the protocols described elsewhere8.                 
            Based on the questionnaire provided in the data collection form and the results of the 
diagnostic tests, patients were classified into four clinico-pathologic stages7. The first among the 
four phases is 'Concealed Phase or Silent Phase'. Though this phase seems to be early in the 
process of disease progression, the risk for sudden death persists, especially during extreme 
exertion. This phase is followed by overt arrhythmic phase then by global right ventricular 
dysfunctional phase. The progression of fibro-fatty replacement at this stage occurs in a diffused 
manner resulting in isolated right heart failure. The final stage conventionally is believed to 
involve the left ventricle causing  bi-ventricular pump failure.                                     
            Since patients were followed up for various durations, from 18 to 72 months, Kaplan 
Meir survival curves were generated using GraphPad Prism 5.                                
Results
Age,   Age   at   onset,   Gender                                                                        
            In the span of three years (2004-2007), 31 ARVD/C cases of Asian-Indian origin were 
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diagnosed with ARVD/C. The age of diagnosis of these patients was extremely variable with the 
youngest patient being four years of age and the oldest being 64 years old and the mean age of 
this cohort of patients was 32.9 ± 16.4. The mean time between onset of ARVD/C related 
symptoms and admission to hospital was about 3 years. Among 31 cases, 19 (61.3%) were males 
with a slight imbalance in male to female ratio (1.46).                                           
Symptoms
               Among the presenting symptoms, 25 (80.6%) of them experienced palpitations, 7 
patients had dyspnea (22.5%), 14 patients had syncope (45.16%), presyncope was present in 4 
patients (12.9%), chest pain was there in 7 (22.5%), swelling of limbs in 6 patients (19.3%), and 
16.2%, i.e., 5 patients were asymptomatic. These 5 asymptomatic patients were detected with 
ARVD/C after the sudden death of a relative or after a confirmed ARVD/C case in the family. 
Though most of the patients experienced the above-described symptoms even during rest, one of 
the patients who was a 56 year old female experienced dyspnea and presyncope particularly on 
physical strain like climbing steps. Another 37 year old male consulted hospital after repeatedly 
experiencing syncope during physical strain. Only one patient in our cohort was involved in 
intense athletic activity.  This patient was 20 year old when there was sudden onset of 
palpitations and dyspnea during participation in athletics.                                                 
Electrocardiographic   studies                                                                  
              12-lead ECG showed sinus rhythm in 74.1% (23) of patients. Most of the patients 
showed normal (~75 beats per minute) heart rate, 19.3% (6) showed ~60 beats per minute and 
one patient with ICD showed 50 beats per minute. T-Wave inversions were observed in 61.2% 
(19) of patients and prolongation of QRS complex, representing prolonged depolarization of 
heart was observed in 20% (6) of cases. Bundle branch block morphology was observed in 60% 
(19) of patients, with 22.2% (7) of them showing left bundle branch block (LBBB). Remaining 
patients showed right bundle branch block morphology (RBBB) reflecting delayed right 
ventricular activation. ECG was highly sensitive test in the present cohort of patients as 100% 
cases showed ECG abnormalities indicative of ARVD/C. ECG of a patient (ID-6) is given in 
Figure 1.
  
Figure 1. ECG of a patient diagnosed according standardized EFC/ISFC criteria.
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Echocardiographic changes                                                                                               
            Right ventricle was found to be dilated to various degrees (from mild to moderate to 
severe) in 80% (25) of the patients and systolic dysfunction was observed in 66.7% (21) patients 
most of them moderately dysfunctional. Tricuspid regurgitation was found to be mild to 
moderate in 53.4%(17) of patients with out pouchings in right ventricle (RV) in 26.7% (8) and 
RV free wall motion abnormalities in 33.4% (10) patients. Right atrium was enlarged in 40% 
(12) of patients but remarkably only one of the patients showed left ventricular involvement. The 
symptoms and clinical features of the patients has been given in Table 1. All the patients were 
followed up from 18 to 72 months and during this time the incidence of sudden death was that of 
1 patient among 31(0.0322) patients and Kaplan Meir survival curves are shown in Figure 2. 
  
Table1. Symptoms and clinical features of all the patients included in the study
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Figure 2. Kaplan Meir survival curve for the cohort of patients included in the present study. The second curve 
gives the individuals at risk at different points of time. These curves were constructed using GraphPad Prism 5.
Comparison of ARVD/C in early onset and late onset cases                                                       
            All the 31 patients were divided into two groups, Group A with patients ≤ 30 years and 
Group B with patients >30 years (Table 2). Number of patients in Group A and Group B were 
similar (16 and 15 respectively) and distribution of these patients with respect to gender was also 
similar with 10 males in Group A and 9 males in Group B. All the five asymptomatic patients 
included in this study were below 30 years of age and therefore belonged to Group A. One of the 
patients who died during the course of this study was a 10-year-old female, with biventricular 
involvement and with the family history of ARVD/C (Ped:2), belonging to Group A. Overall, 
positive family history with either a confirmed case of ARVD/C or with a sudden death of 
unknown cause was observed in 62.5% (10 patients) in group A and 33.3% (5 patients) in group 
B. However the difference between the two groups did not show statistical significance 
(P=0.2666), so a larger sample size is required to corroborate the findings.
Table 2. Gives the comparison of ARVD/C in Group A (≤30years) and Group B (>30 years)
P=0.266683448
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Familial   studies                                                                      
            After confirming the diagnosis of ARVD/C, only six of the patients gave consent for 
screening the family members with most of them refusing to involve other family members 
probably due to social problems. Among the six patients, three of the families showed positive 
family history of ARVD/C, where the relatives showed abnormalities in clinical tests but were 
asymptomatic.
            First of these patients with family history was a 55 year old female with symptoms of 
palpitations, syncope, chest pain and swelling of right limbs. The heart showed 50 beats per 
minute with sinus rhythm and QRS duration of 100 ms and left axis deviation. T-wave 
inversions were observed in leads V2-V3. This patient was implanted with AICD (automatic 
implantable defibrillator). Family history revealed sudden death of 2 of her siblings with 
unknown cause. This patient satisfied 1 major and 2 minor criteria for the confirmation of 
diagnosis. Screening the available family members, II-3, III-1, III-2 and IV-1 (Figure 3. Ped:1) 
revealed normal echocardiography and ECG in all of them except IV-1 who was aged 4 years, 
showed the symptoms of palpitations and on signal averaged ECG (SAECG) revealed premature 
ventricular complexes (PVCs), revealing the familial nature of the condition in this case. 
Figure 3. Pedigree 1
 
            Second patient was a 10-year-old girl who had complained of repeated episodes of 
syncope. After the diagnosis of ARVD/C, the condition was considered to be extremely 
progressive with biventricular involvement and heart transplantation was being considered 
within one year of diagnosis as the next treatment option. But she expired during this period 
even when she was on medication. Clinical examination of the family members revealed three of 
the relatives, II-2, II-7 and IV-2 satisfying 1- major criteria of confirmed case of ARVD/C in the 
family and 2 minor criteria of T-wave inversions in right precordial leads and  sudden death of a 
relative (father of proband (II-8)) at about 30 years of age without any known cause (Figure 4. 
Ped:2).
            Third patient was a 53-year-old female showing the symptoms of dyspnea on exertion 
(Grade III) and palpitations (Grade II) with the diagnosis being done 2 years ago. Magnetic 
resonance imaging (MRI) revealed abnormalities of right ventricular morphology and 24 hour 
Holter showed VT (ventricular tachycardia) from right ventricular outflow tract. Three other 
members of this family, II-2, III-1 and III-3 were found to have the characteristics of ARVC on 
clinical   examination   (Figure   5.  Ped:3).                                                            
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Figure 4.  Pedigree: 2
 
Figure 5.  Pedigree: 3
 
Classification of patients into clinico-pathologic phases                                   
            Among 31 patients included in our study, though 5 patients were asymptomatic, their 
ECG and 2D-Echocardiography showed gross to mild structural and functional variations. 
Therefore they could not be classified into the first phase of Concealed/Silent phase, as this 
phase   is   characterized   by   subtle   or   no   structural   changes.                                    
              23   patients (74%) in the given cohort showed ECG abnormalities such as T-wave 
inversions   characteristic   of   right   ventricular   pathology   and   right   ventricle   showed 
echocardiographic variations such as   mild segmental dilatation, localized aneurysms, mild 
global right ventricular dilatation and also regional right ventricular hypokinesia, all of them 
having resemblance with   typical ARVD/C hearts.                                                         
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            Seven patients (22.5%) showed features more progressive than the majority of patients 
leading to right heart failure or severe global right ventricular dysfunction. These patients can be 
tentatively classified into the third phase of  Global right ventricular dysfunctional  phase.
            One of the 10 year old patients (Ped: 2) had biventricular involvement with severe 
dysfunction.   This   patient   can   be   classified   into   the   final   stage.
            Overall, all the 31 patients satisfied task force criteria with minimum of 1 major and 2 
minor   or   2   major   or   4   minor   criteria.                                                            
Discussion
            Previous  reports on clinical manifestation of this condition reveal that ARVD/C shows 
wide clinical heterogeneity among patients from various geographic areas2,9,10. This study is an 
attempt to describe the clinical manifestations of ARVD/C in Asian-Indian population.  
            Mean age of onset in the present cohort is 32.9 ± 16.4 years, which  is about a decade 
earlier than other Asian cohort of patients (Chinese,42 ± 14.8 years and Korean, 41.2 ± 14.8 
years)5,10. This could be due to the fact that about 50% (16 out of 31) of patients were below 30 
years of age and four of these individuals were less that 10 years of age (2 patients 4 years, 1 
patient 7 years and 1 patient 10 years of age). This early onset of ARVC could be due to genetic 
differences   between   these   populations.                                                                
            Some early studies have reported male preponderance in ARVD/C11 to the extent of 3:1  
and most of the reports on this condition show atleast slight male preponderance. This study 
shows male to female ratio to be 1.46, slightly infavour of males, which could be due to 
environmental factors that increase oxidative stress such as tobacco smoking and alcohol, which 
is predominantly observed in males among Indians. Alternately, this could be due to the  genetic 
modifying factors that   may predispose males to the condition.                                         
               Previous reports on ARVD/C have shown that this condition is the   second most 
common cause of sudden death in athletes12. In the present report, only one patient was a 
professional athlete at the local district level and only 2 patients experienced symptoms on 
physical strain. Therefore in this cohort of population ARVD/C is not triggered only during 
intense physical strain but also is observed in normal population without any athletic activity.
               Though ARVD/C is predominantly a right ventricular condition, recent studies 
implicated increased left ventricular involvement, not only as a pathogenic progression to left 
ventricle, but also in patients in initial stages of ARVD/C13,14. In our study, none of the patients 
showed predominant left ventricular pathology except in one case where left ventricle was 
involved after gross right ventricular stages. Other reason for reduced number of patients with 
left ventricular involvement in present study could be due to the bias in diagnosis, as the patients 
were detected based only on standardized task force criteria which presently do not include left 
ventricular   pathology.                                                                    
            The comparison of ARVD/C among early onset (below 30 years of age) and late onset 
(above 30 years of age) cases showed that there was an increased number of asymptomatic cases 
in early onset group. These patients could not be classified under early stages of ARVD/C 
because they showed typical pathology of right ventricle such as localized aneurysms, segmental 
dilation and mild global right ventricular dilatations. This indicates that in these early onset 
cases, the pathology of right ventricle progresses silently, with out manifestation of any signs of 
pathogenic condition, that may finally lead to sudden death. Triggering of symptoms may 
require age-related environmental factors. Further, genetic lesions causing mutations could be 
playing major role in early onset cases as more than 60% of early onset group indicated familial 
nature   of   ARVD/C.                                                                        
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            It has been reported that about 50% of ARVD/C cases are familial in nature11. In the 
present study, among 31 patients, 15 patients revealed familial history of sudden death of 
unknown cause or a confirmed case of ARVD/C. We could not carry out clinical diagnostic tests 
in all the family members of 31 patients as most of the patients were not willing to participate in 
the   study.                                                                                  
            Among the families studied, the age of onset of symptoms was found to earlier in the 
younger generations compared to the older generations. Also, one of the family was highly 
asymptomatic in most of the affected individuals. These peculiar features of disease inheritance 
viz., genetic anticipation and asymptomatic nature of ARVD/C observed in these families could 
be due to different genetic etiologies, as genetic heterogeneity in ARVD/C is well documented15. 
            Though it is not necessary that all the ARVD/C patients would show defined stages in 
the disease expression, nevertheless, Thiene et al7 empirically defined the course of ARVD/C 
into four clinicopathologic phases. Most of the patients (23/31) were under the category of overt 
arrhythmic phase in which the features of the right ventricle are similar to typical ARVD/C 
hearts. This also may represent sample bias as most of the patients at this stage are more 
detectable, than in silent phase or in biventricular failure phase. In biventricular failure phase, it 
is more likely that the condition is misdiagnosed as dilated cardiomyopathy.                 
Conclusion
            Our study suggests that ARVC is responsible for cardiac pathology in young Indians. We 
recommend that individuals with a diagnosis of ARVD have family screening to assess for the 
presence ARVC in asymptomatic family members. If family screening is routinely performed 
the incidence of premature SCD will be reduced.                                                     
Limitations
            Due to the difficulties associated with the diagnosis of ARVC, there is a chance that 
many cases obtained during this time could have been misdiagnosed as some other condition and 
could   be   responsible   for   lower   sample   size.                                                
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